North America Unit Dose Manufacturing Market Analysis Report 2021-2028 –

North America Unit Dose Manufacturing Market Analysis Report 2021-2028 –

North America Unit Dose Manufacturing Market Analysis Report 2021-2028 –

DUBLIN–(BUSINESS WIRE)–The “North America Unit Dose Manufacturing Market Size, Share & Trends Analysis Report By Source (In-house, Outsourcing), By Product, By End Use (Independent Pharmacies, Long Term Care Facility), By Country, And Segment Forecasts, 2021 – 2028” report has been added to’s offering.

The North America unit dose manufacturing market size is expected to reach USD 21.7 billion by 2028 and is expected to expand at a CAGR of 16.9% from 2021 to 2028

The rapidly growing pharmaceutical industry and rising demand for unit doses are factors driving the market.

Single-dose packaging has certainly become one of the most popular recent trends. The most obvious benefit is its ease of use and improved medication management, as they can be prescribed by the unit, ensuring that the person taking it does not exceed the prescribed dose. Stick packs are unique in the way that they can be used to package a variety of items, both dry and wet.

Measuring cups, teaspoons, tablespoons, and multi-dose containers for oral liquids and eye drops have been already seen. The current patient is seeking convenience. Doctors are also appreciating the importance of unit dose in prescription writing since it allows them to prescribe controlled substance oral liquid without concern of abuse as unit doses address the issue.

It also enables pharmacists to store oral liquids in a secure manner, which is a significant additional benefit. Nearly every single unit dose oral solid or multiple-dose oral liquid could be transformed to a unit dose oral liquid due to this innovation.

However, owing to the COVID-19 pandemic’s repercussions, the unit dose manufacturing market increased at a modest 11.0% year over year in 2020. By the end of 2020, the market started to recover. COVID-19-related illnesses are being treated using unit dosages.

Hospitals have updated and implemented various new standard operating procedures to protect both patients and healthcare workers. As a consequence, it’s crucial to consider out viral transmission by airborne transmission or direct contact. When unit dose medicines are used, some of the risks involved with handling and pouring doses from the same bottle are reduced.

North America Unit Dose Manufacturing Market Report Highlights

  • The outsourcing segment dominated the market and accounted for the largest revenue share of 59.6% in 2020. Unit doses lead to the minimization of credits for drugs coupled with greater control by a pharmacist over work patterns and schedules
  • The solid unit dose segment held 49.1% of the revenue share in 2020. In 2018, oral solid dosage medicines accounted for 53% of all new pharmaceuticals approved by the FDA
  • The independent pharmacies segment dominated the market and accounted for the largest revenue share of 34.1% in 2020
  • The hospital segment held the second-largest revenue share in 2020. The segment is estimated to become 3.5 times of itself by 2028

Market Dynamics

Market Driver Analysis

  • Increased Adoption of Unit Doses
  • Benefits of manufacturing unit doses over repackaging
  • Flourishing pharmaceutical industry

Market Restraint Analysis

  • Challenges associated with the adoption of manufactured unit doses

North America Unit Dose Manufacturing: Market Analysis Tools

  • Industry Analysis – Porter’s
  • PESTEL Analysis

Penetration & Growth Prospect Mapping

COVID-19 Impact on the Market

Major Deals and Strategic Alliances Analysis

Companies Mentioned

  • Catalent Inc
  • Unither Pharmaceuticals
  • ThermoFisher Pantheon
  • Corden Pharma.
  • Mikart
  • Tape Mark
  • Renaissance Lakewood LLC
  • Medical Packaging Inc
  • American Health Packaging

For more information about this report visit


Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900